• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
LeMaitre Vascular, Inc. (LMAT) Stock Price, News & Analysis

LeMaitre Vascular, Inc. (LMAT) Stock Price, News & Analysis

Currency in USD Disclaimer

$107.83

$1.96

(1.84%)

Day's range
$106.1
Day's range
$108.09
50-day range
$84.69
Day's range
$108.09
  • Country: US
  • ISIN: US5255582018
52 wk range
$51.7
Day's range
$108.09


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 33.86
  • Piotroski Score 7.00
  • Grade Outperform
  • Symbol (LMAT)
  • Company LeMaitre Vascular, Inc.
  • Price $107.83
  • Changes Percentage (1.84%)
  • Change $1.96
  • Day Low $106.10
  • Day High $108.09
  • Year High $108.09

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

  • Last Earnings 10/31/2024
  • Ex-Dividend for 5/16 Dividend 11/21/2024
  • Dividend Payable 12/05/2024
  • Today N/A
  • Next Earnings (Estimated) 02/20/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $85.50
  • High Stock Price Target $100.00
  • Low Stock Price Target $70.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $1.51
  • Trailing P/E Ratio 51.31
  • Forward P/E Ratio 51.31
  • P/E Growth 51.31
  • Net Income $30.11 M

Income Statement

Quarterly

Annual

Latest News of LMAT

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

LeMaitre Vascular, Inc. Frequently Asked Questions

  • What were the earnings of LMAT in the last quarter?

    In the last quarter LeMaitre Vascular, Inc. earnings were on Thursday, October, 31st. The LeMaitre Vascular, Inc. maker reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.44 by $0.05.

  • What is the LeMaitre Vascular, Inc. stock price today?

    Today's price of LeMaitre Vascular, Inc. is $107.83 — it has increased by +1.84% in the past 24 hours. Watch LeMaitre Vascular, Inc. stock price performance more closely on the chart.

  • Does LeMaitre Vascular, Inc. release reports?

    Yes, you can track LeMaitre Vascular, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the LeMaitre Vascular, Inc. stock forecast?

    Watch the LeMaitre Vascular, Inc. chart and read a more detailed LeMaitre Vascular, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is LeMaitre Vascular, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by LeMaitre Vascular, Inc. stock ticker.

  • How to buy LeMaitre Vascular, Inc. stocks?

    Like other stocks, LMAT shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is LeMaitre Vascular, Inc.'s EBITDA?

    LeMaitre Vascular, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in LeMaitre Vascular, Inc.’s financial statements.

  • What is the LeMaitre Vascular, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.155594261, which equates to approximately 15.56%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in LeMaitre Vascular, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including LeMaitre Vascular, Inc.'s financials relevant news, and technical analysis. LeMaitre Vascular, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for LeMaitre Vascular, Inc. stock currently indicates a “sell” signal. For more insights, review LeMaitre Vascular, Inc.’s technical analysis.

  • A revenue figure for LeMaitre Vascular, Inc. for its last quarter?

    LeMaitre Vascular, Inc. published it's last quarterly revenues at $54.82 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.